Allergan's €42m investment boosts Irish manufacturing and jobs
Allergan has committed €42m ($44m) to increase capacity and capabilities at two manufacturing facilities in Ireland.
Archives for March 2, 2017
US FDA clears Akorn's generic CellCept after Form 483 resolved
The US FDA has cleared Akorn Inc. to sell a generic version of the immunosuppressant CellCept made at its plant in Decatur, Illinois.
update
EU and US agree to share API and drug plant inspection data
The EU and US have agreed to recognize drug and API manufacturing plant inspections conducted in their respective territories under a deal signed this week.
Quartesian hiring 100 employees in 2017 as it expands globally
Quartesian is opening new and expanded offices in Bangalore and Chennai, India and Kiev, Ukraine to help support its plans to double bookings in 2017.
Brexit and EU regulations motivate Quotient US buyouts
UK-based Quotient Clinical’s CEO cites Brexit and upcoming changes in European trial regulations as the motivation for acquiring US CDMO businesses.
Ashfield rolls in cloud service to speed up market launch
UDG’s Ashfield division will use Salesforce Health Cloud to help outsource clients launch therapies into EU and US markets through “seamless” data exchange.
Preclinical CRO PharmOptima joins GBG research consortium
Genesis Biotechnology Group (GBG) has acquired the preclinical CRO PharmOptima in order to provide customers with a single point-of-contact throughout their drug development programs.
Turmeric bioavailability enhancer could be used with APIs, Wacker
Wacker Biosolutions says an excipient shown to increase the bioavailability of a food supplement by a factor of 40 could have implications in the API space.